IARC

IARC has published the new fourth edition of the International Classification of Diseases for Oncology (ICD-O-4) tables on the @WHO Classification of Tumours Online website. View them today! iarc.who.int/news-events/in…

IARC hosted final meeting of current phase of EC-CvC, the Working Group was established to develop evidence-based recommendations to shape #CervicalCancer prevention in 🇪🇺. Public consultation on the draft recommendations is expected to begin by end 2026. iarc.who.int/news-events/ia…

🆕study from IARC & @CLCCLeonBerard provides novel evidence on how excess adiposity may increase risk of #PancreaticCancer. Study in the @BrJCancer finds higher blood glucose levels explain ~20% of increased pancreatic cancer risk associated with obesity. iarc.who.int/news-events/st…

🇹🇿The summary report of the June 2026 @IAEAorg, @WHO, @IARCWHO imPACT Review to Tanzania is now available online! ➡️Read it here: bit.ly/3RqAec0

The @WHO Africa Region @WHOAFRO is expected to see the largest % increase in cancer incidence by 2050. The latest #GLOBOCAN estimates project the number of cases to more than double, rising by 125% compared with 2024 cases. iarc.who.int/news-events/wh…

IARC, @WHO, & partners, reveal scale of disparities in global #BreastCancer survival with launch of 1st-ever WHO Global Breast Cancer Survival Estimates in @NatureMedicine. New figures provide global benchmark for monitoring breast cancer outcomes. iarc.who.int/news-events/gl…

The latest #GLOBOCAN estimates from IARC & @AmericanCancer Society suggest that 1 in 5 people develop cancer during their lifetime. 1 in 9 men & 1 in 13 women die from the disease. Explore more of the latest data on IARC’s #Globocan platform. iarc.who.int/news-events/gl…

The latest estimates of global cancer incidence & mortality are now available! IARC estimates that, in 2024, 20.6 million new cases of cancer were diagnosed & 9.8 million people died of cancer. The🆕data can be found & explored on IARC’s #Globocan platform iarc.who.int/news-events/gl…

IARC & @WHO launch the WHO Global Status Report on #Cancer 2026! The Global Status Report was developed jointly by IARC & WHO to provide the most comprehensive analysis of progress across e.g., political commitment, prevention, & investment in treatment. iarc.who.int/news-events/wh…

Researchers from IARC & partners provide 1st-of-kind evidence for presence of tobacco-specific nitrosamine mutational signature in human tumours. Signature may contribute to mutational landscape during development of certain cancers linked to tobacco use. iarc.who.int/news-events/hu…

Don't forget, the IARC Monographs classifications indicate strength of evidence that a substance can cause #cancer, not the cancer risk associated with different routes & levels of exposure. Agents in the same Group can have very different cancer risk.

For BBzP, DBP, & DINP, mechanistic evidence was strong, & the evidence for cancer in animals was either sufficient (BBzP & DINP) or limited (DBP). Evidence for cancer in humans was inadequate . The Working Group evaluated BBzP, DBP, & DINP as possibly carcinogenic to humans, 2B.

An #IARCMonographs📙 Working Group evaluated butyl benzyl phthalate (BBzP), dibutyl phthalate (DBP), & diisononyl phthalate (DINP) as possibly carcinogenic to humans, Group 2B. iarc.who.int/news-events/ia… What does that mean?🧵

The results of the #IARCMonographs📙 evaluations of butyl benzyl phthalate (BBzP), dibutyl phthalate (DBP), & diisononyl phthalate (DINP) have been published in @TheLancetOncol. The Working Group evaluated each as possibly carcinogenic to humans, Group 2B iarc.who.int/news-events/ia…

The results of the #IARCMonographs📙 evaluation of 3 chemicals (butyl benzyl phthalate (BBzP), dibutyl phthalate (DBP), & diisononyl phthalate (DINP)) have been published in @TheLancetOncol. The article presents the conclusions of Monographs Meeting 142 iarc.who.int/news-events/ia…

IARC launches new website to support ECCE project ECCE aims to uncover unknown causes of colorectal cancer, particularly of colorectal cancer in people aged less than 50 years old. iarc.who.int/news-events/ia…

📸Thesealyman fr.wikipedia.org/wiki/Suzette_D…

Le Circ adresse ses plus chaleureuses félicitations à la Dre Suzette Delaloge pour sa nomination à la présidence de l'@Institut_cancer. Nous nous réjouissons de poursuivre notre collaboration et notre engagement commun au service de la prévention du cancer, en 🇫🇷 et bien au-delà.